Ghe LLC boosted its position in Colgate-Palmolive (NYSE:CL – Free Report) by 1.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 20,938 shares of the company’s stock after acquiring an additional 338 shares during the quarter. Colgate-Palmolive makes up 0.9% of Ghe LLC’s investment portfolio, making the stock its 24th biggest position. Ghe LLC’s holdings in Colgate-Palmolive were worth $2,138,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Bleakley Financial Group LLC raised its stake in shares of Colgate-Palmolive by 3.8% in the 1st quarter. Bleakley Financial Group LLC now owns 20,832 shares of the company’s stock valued at $1,876,000 after purchasing an additional 767 shares in the last quarter. Dearborn Partners LLC raised its stake in Colgate-Palmolive by 4.6% during the first quarter. Dearborn Partners LLC now owns 7,329 shares of the company’s stock worth $660,000 after acquiring an additional 323 shares during the period. TD Asset Management Inc raised its stake in Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock worth $103,969,000 after acquiring an additional 26,987 shares during the period. State Board of Administration of Florida Retirement System raised its stake in Colgate-Palmolive by 3.5% during the first quarter. State Board of Administration of Florida Retirement System now owns 988,091 shares of the company’s stock worth $88,978,000 after acquiring an additional 33,093 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Colgate-Palmolive by 12.9% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,103,745 shares of the company’s stock worth $99,392,000 after acquiring an additional 126,456 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Insider Activity
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.37% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on CL
Colgate-Palmolive Price Performance
Shares of CL stock traded up $0.09 during trading on Wednesday, hitting $91.59. The company had a trading volume of 210,756 shares, compared to its average volume of 4,357,673. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock’s 50-day moving average is $100.30 and its two-hundred day moving average is $98.53. The stock has a market capitalization of $74.83 billion, a price-to-earnings ratio of 26.22, a price-to-earnings-growth ratio of 3.28 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $75.17 and a 52 week high of $109.30.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- How Investors Can Find the Best Cheap Dividend Stocks
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What is a buyback in stocks? A comprehensive guide for investors
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
- How is Compound Interest Calculated?
- Is Palantir’s AI Edge Enough to Justify Its Price?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.